Filter By Category
Archives
Share on -
AZITIRELIN
Generic Name: AZETIRELIN
ABSTRACT -
Azetirelin, also known as YM-14673, is a synthetic thyrotropin-releasing hormone (TRH) analog. It has been studied for central nervous system effects and for stimulation of pituitary hormone release. It is a peptide-like small molecule rather than a conventional marketed medicine in most regions. Molecular formula: C₁₅H₂₀N₆O₄; molecular weight: 348.36 g/mol. Development/regulatory status: Investigational/research compound.
This document is for structured API information only. It is not a prescribing guide. Clinical use, if any, must follow the approved local label, trial protocol, and specialist medical supervision.
DOSAGE-
- No approved routine dosing schedule is established for general clinical use.
- Any administration should follow a research protocol or specialist endocrine/neurology supervision.
- Dose selection depends on route, indication, endocrine status, and monitoring of TSH, prolactin, and vital signs.
- Do not use without clinician oversight.
SIDE EFFECTS-
Possible side effects and safety concerns include:
- Headache, dizziness, flushing, nausea, or gastrointestinal discomfort
- Changes in heart rate, blood pressure, or body temperature
- Endocrine effects such as altered TSH or prolactin release
- Anxiety, restlessness, or CNS stimulation in sensitive patients
- Injection-site or hypersensitivity reactions
ALLERGIC REACTIONS -
Hypersensitivity to azetirelin or related compounds/products may occur. Symptoms may include:
- Infusion reaction or injection-site reaction where applicable
- Rash or urticaria
- Bronchospasm or breathing difficulty
- Facial, lip, tongue, or throat swelling
- Anaphylaxis
Important: Patients who develop an allergic reaction to azetirelin should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS-
- Thyroid hormone therapy, antithyroid drugs, dopamine agonists, and pituitary-axis medicines may alter endocrine response.
- CNS-active drugs may complicate neurologic assessment.
- Medicines affecting heart rhythm or blood pressure require caution.
- Patients should disclose all medicines, supplements, and hormonal therapies.
PREAUTIONS–
- Monitor endocrine laboratory response and vital signs when used experimentally.
- Use caution in thyroid disease, pituitary disorders, cardiovascular disease, seizure disorders, pregnancy, or lactation.
- Not intended for unsupervised diagnostic or therapeutic use.
WARNINGS –
- Can alter endocrine and neurologic responses.
- Seek urgent care for severe allergic reaction, chest pain, severe agitation, or neurologic events.
- Keep out of reach of children.
Share on -
. Developed by